BioNexus Gene Lab Corp Common stock (BGLC) — Free Cash Flow Generation Index
BioNexus Gene Lab Corp Common stock (BGLC) has a Free Cash Flow Generation Index of 0.96x as of December 2022. Free cash flow of $457.44K represents 1% of operating cash flow ($474.47K). Explore BioNexus Gene Lab Corp Common stock capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
BioNexus Gene Lab Corp Common stock Free Cash Flow Generation Index (2017–2022)
Historical FCF Generation Index trend for BioNexus Gene Lab Corp Common stock across 4 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of BioNexus Gene Lab Corp Common stock.
Annual Free Cash Flow Generation for BioNexus Gene Lab Corp Common stock (2017–2022)
Year-by-year Free Cash Flow Generation Index for BioNexus Gene Lab Corp Common stock. Check BGLC cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.90x | $489.86K | $544.03K | $54.17K | ▲ +37.5% |
| 2021 | 0.65x | $6.00K | $9.16K | $3.16K | ▲ +176.1% |
| 2020 | 0.24x | $131.06K | $552.68K | $421.62K | ▲ +99.8% |
| 2017 | 0.12x | $42.40K | $357.22K | $314.82K | — |